Evidence map›Paper›PMID 29180618›Full record

ArticleNature communications2017

A transcribed enhancer dictates mesendoderm specification in pluripotency.

Michael Alexanian, Daniel Maric, Stephen P Jenkinson, Marco Mina, Clayton E Friedman, Ching-Chia Ting, Rudi Micheletti, Isabelle Plaisance, Mohamed Nemir, Damien Maison and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Genes & diseases · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Transcriptional plasticity of fibroblasts in heart disease.Biochemical Society transactions · 2022
    Review
  11. Enhancer RNA (eRNA) in Human Diseases.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Emerging Functions of lncRNA Loci beyond the Transcript Itself.International journal of molecular sciences · 2022
    Review
  14. LncRNAs at the heart of development and disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2022
    Review
  15. Article
  16. A mechanistic view of long noncoding RNAs in cancer.Wiley interdisciplinary reviews. RNA · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Michael AlexanianExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland.
Daniel MaricExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland.
Stephen P JenkinsonNeuroinfectiology Laboratory, Institute for Infectious Diseases, University of Bern, 3001, Bern, Switzerland.
Marco MinaDepartment of Computational Biology, University of Lausanne, 1011, Lausanne, Switzerland.
Clayton E FriedmanThe Institute for Molecular Bioscience, University of Queensland, 4067, Brisbane, Australia.
Ching-Chia TingExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland.
Rudi MichelettiExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland.
Isabelle PlaisanceExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland.
Mohamed NemirExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland.
Damien MaisonExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland.
Jasmin KernenNeuroinfectiology Laboratory, Institute for Infectious Diseases, University of Bern, 3001, Bern, Switzerland.
Iole PezzutoExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland.
Dominic VilleneuveCenter for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015, Lausanne, Switzerland.
Frédéric BurdetSwiss Institute of Bioinformatics, 1015, Lausanne, Switzerland.
Mark IbbersonSwiss Institute of Bioinformatics, 1015, Lausanne, Switzerland.
Stephen L LeibNeuroinfectiology Laboratory, Institute for Infectious Diseases, University of Bern, 3001, Bern, Switzerland.
Nathan J PalpantThe Institute for Molecular Bioscience, University of Queensland, 4067, Brisbane, Australia.
Nouria HernandezCenter for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015, Lausanne, Switzerland.
Samir OunzainExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland. samir.ounzain@chuv.ch.
Thierry PedrazziniExperimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011, Lausanne, Switzerland. thierry.pedrazzini@chuv.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enhancers and long noncoding RNAs (lncRNAs) are key determinants of lineage specification during development. Here, we evaluate remodeling of the enhancer landscape and modulation of the lncRNA transcriptome during mesendoderm specification. We sort mesendodermal progenitors from differentiating embryonic stem cells (ESCs) according to Eomes expression, and find that enhancer usage is coordinated with mesendoderm-specific expression of key lineage-determining transcription factors. Many of these enhancers are associated with the expression of lncRNAs. Examination of ESC-specific enhancers interacting in three-dimensional space with mesendoderm-specifying transcription factor loci identifies MesEndoderm Transcriptional Enhancer Organizing Region (Meteor). Genetic and epigenetic manipulation of the Meteor enhancer reveal its indispensable role during mesendoderm specification and subsequent cardiogenic differentiation via transcription-independent and -dependent mechanisms. Interestingly, Meteor-deleted ESCs are epigenetically redirected towards neuroectodermal lineages. Loci, topologically associating a transcribed enhancer and its cognate protein coding gene, appear to represent therefore a class of genomic elements controlling developmental competence in pluripotency.

Indexed as

AnimalsCell DifferentiationCell LineCell LineageEctodermEmbryonic Stem CellsEnhancer Elements, GeneticGene Expression ProfilingGene Expression Regulation, DevelopmentalHumansInduced Pluripotent Stem CellsMesodermMiceNeural PlateRNA, Long NoncodingRNA, Long Noncoding

Identifiers

PMID29180618
PMCPMC5703900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.